FMP

FMP

Enter

AKUS - Akouos, Inc.

photo-url-https://images.financialmodelingprep.com/symbol/AKUS.png

Akouos, Inc.

AKUS

NASDAQ

Inactive Equity

Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. The company was incorporated in 2016 and is based in Boston, Massachusetts.

13.29 USD

0 (0%)

Historical Prices

From:

To:

page loading card

About

ceo

Dr. Emmanuel Simons M.B.A., Ph.D.

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. The c...

CIK

0001722271

ISIN

US00973J1016

CUSIP

00973J101

Address

645 Summer Street

Phone

857 410 1818

Country

US

Employee

103

IPO Date

Jun 26, 2020

Financial Statement

page loading card

Earnings

We are unable to load the chart at this time.

fmp-logo

AKUS Financial Summary

CIK

0001722271

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

00973J101

ISIN

US00973J1016

Country

US

Price

13.29

Beta

-0.56

Volume Avg.

725.97k

Market Cap

0

Shares

-

52-Week

2.315-13.6

DCF

0

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-4.69

P/B

-

Website

https://www.akouos.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo
page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep